Breast cancer is the most common neoplasia among women worldwide, representing a significant public health challenge. In Brazil, tens of thousands of new cases are estimated to arise each year, reinforcing the need for effective strategies for prevention, early diagnosis, and proper treatment.<\/p>\n
Breast cancer<\/strong> is the most common neoplasia among women worldwide, representing a significant public health challenge. During Breast Cancer Awareness Month<\/strong>, awareness campaigns draw attention to the importance of screening<\/strong> and women’s health care<\/strong>. However, along with the dissemination of information, myths and doubts about the true risk factors for breast cancer<\/strong> also arise.<\/p>\n It is essential for doctors to be well informed to safely guide their patients, differentiating proven risk factors<\/strong> \u2014 such as smoking, alcohol, obesity, and physical inactivity<\/strong> \u2014 from those that are often mistakenly associated, such as hormone replacement therapy (HRT)<\/strong> during menopause.<\/p>\n For years, HRT was pointed out as one of the main causes of breast cancer. However, new scientific evidence<\/strong> has revised this perspective. The main conclusion was clear:<\/p>\n HRT, when well indicated and monitored, should not be considered a villain.<\/strong> When analyzing population data, it is evident that lifestyle habits<\/strong> have a much greater influence on the risk of breast cancer than HRT.<\/p>\n These factors are modifiable<\/strong> and should be the main focus of prevention strategies.<\/p>\n More than restricting hormonal therapies that improve quality of life, it is essential that the physician acts as an educator<\/strong>, helping the patient understand her real risks<\/strong> and adopt healthy habits<\/strong>.<\/p>\n Moreover, the risk of developing breast cancer is not the same for all women<\/strong>. It varies according to family history, genetic predisposition, environment, and lifestyle. Personalized medicine<\/strong> allows for a better understanding of each patient’s individual risk. The MyHormoDNA Breast and Ovarian Cancer Panel<\/strong> is an advanced tool that offers:<\/p>\n This approach promotes a personalized, safe, and evidence-based medical practice<\/strong>.<\/p>\n The debate on HRT and breast cancer<\/strong> needs to be revised in light of current science. Do you want to better understand how to assess your patients’ individual risk? Prepared by Dr. Francisco Tostes, Scientific Director at Renewal<\/em><\/p><\/p>\n","protected":false},"excerpt":{"rendered":" Breast cancer is the most common neoplasm among women worldwide, representing a significant public health challenge. In Brazil, it is estimated that tens of thousands of new cases arise each year, reinforcing the need for effective strategies for prevention, early diagnosis, and appropriate treatment.<\/p>\n","protected":false},"author":0,"featured_media":710,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_rwl_seo_title":"","_rwl_seo_description":"","_rwl_seo_noindex":"","footnotes":""},"categories":[7,5],"tags":[],"class_list":["post-709","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-clinical-practice","category-providers-blog"],"_links":{"self":[{"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/posts\/709","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/comments?post=709"}],"version-history":[{"count":6,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/posts\/709\/revisions"}],"predecessor-version":[{"id":844,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/posts\/709\/revisions\/844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/media\/710"}],"wp:attachment":[{"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/media?parent=709"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/categories?post=709"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewalhow.com\/usa\/wp-json\/wp\/v2\/tags?post=709"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
In Brazil, it is estimated that tens of thousands of new cases<\/strong> arise each year, reinforcing the need for effective strategies for prevention, early diagnosis, and proper treatment<\/strong>.<\/p>\nWhat really increases the risk of breast cancer?<\/strong><\/h2>\n
In a recent panel by the FDA (Food and Drug Administration)<\/strong>, specialists highlighted that the relationship between HRT and breast cancer is much more complex than previously thought<\/strong>.<\/p>\n
<\/strong> The risk is modest and variable<\/strong>, depending on the type of formulation, duration of use, and, most importantly, the genetic and clinical profile of the patient<\/strong>.<\/p>\nThe impact of lifestyle habits on breast cancer<\/strong><\/h2>\n
\n
The role of the physician: information and individualization<\/strong><\/h2>\n
Therefore, individualized genetic assessment<\/strong> has become an essential ally in modern medical practice.<\/p>\nGenetics and personalized medicine: the future of prevention<\/strong><\/h2>\n
Through specific genetic tests<\/strong>, it is possible to identify variants associated with breast cancer predisposition<\/strong>, such as BRCA1, BRCA2, TP53, PALB2, ATM, and CHEK2<\/strong>.<\/p>\n\n
Conclusion: it\u2019s time to update the debate<\/strong><\/h2>\n
Hormonal replacement, when well indicated and monitored, should not be seen as a cause of breast cancer<\/strong>.
The real focus should be on modifiable risk factors<\/strong> \u2014 such as lifestyle habits \u2014 and on individualized genetic assessment<\/strong>.<\/p>\n
Contact us and learn about the MyHormoDNA genetic tests<\/strong>, designed to offer security, personalization, and clinical precision<\/strong>.<\/p>\nReferences<\/strong><\/h3>\n
\n